According to GlobalData’s medical device pipeline database, 39 Breast Implants devices are in various stages of development globally. GlobalData’s report Breast Implants provides an overview of the segment’s pipeline landscape and offers detailed analysis of its products. Buy the report here.
Of these devices, 35 are in active development, while the remaining ten are in an inactive stage of development. There are eight products in the early stages of development, and the remaining 27 are in the late stages of development.
Breast Implants includes the Sizers, Expanders, Round gel Implants, Saline Implants and Shaped gel Implants.
Innovations in the medical devices sector are linked to the development of new approaches, processes, or technologies for treating, diagnosing, and managing disease in response to demand from healthcare for better patient outcomes and reduce healthcare costs.
Based on an analysis of GlobalData’s Medical Intelligence Center pipeline product database, these actively developed Breast Implants pipeline devices are all expected to be approved within the next ten years.
Currently, private organizations, public entities and institutions are working on the development of Breast Implants devices. Overall, most of these Breast Implants pipeline devices are being developed by private entities.
Key players involved in the active development of Breast Implants include Establishment Labs, Allergan Aesthetics, BellaSeno, Collplant Biotechnologies, 3D Bio, BioPlus, Biostruxs, Apex Medical Device Design, Arula Technolgies and FixNip.
For a complete picture of the developmental pipeline for Breast Implants devices, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.